Details of the Drug
General Information of Drug (ID: DMGD7JM)
Drug Name |
D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
D-Phenylalanyl-N-(3-Chlorobenzyl)-L-Prolinamide; CHEMBL321130; CHEMBL599035; 628262-82-8; 22U; CTK1I8953; DTXSID70648418; BDBM50133531; BDBM50307858; DB06919; D-Phenylalanyl-N-[(3-chlorophenyl)methyl]-L-prolinamide; L-Prolinamide, D-phenylalanyl-N-[(3-chlorophenyl)methyl]-; N-(3-Chlorobenzyl)-1-[(2R)-2-amino-3-phenylpropionyl]-L-prolinamide; (S)-1-((R)-2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid 3-chloro-benzylamide; (S)-1-((R)-2-amino-3-phenylpropanoyl)-N-(3-chlorobenzyl)pyrrolidine-2-carboxamide hydrochlo
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 385.9 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||